ArticleJournal of surgical case reports2025
Liver metastases from oropharyngeal squamous cell carcinoma: a rare case report.
Article in Journal of surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oropharyngeal squamous cell carcinoma (OPSCC) commonly metastasizes to the lungs, bones, and distant lymph nodes. Liver metastases from OPSCC are rare and typically occur in advanced stages. We present a 59-year-old male diagnosed with OPSCC, initially treated with surgery followed by adjuvant radiotherapy (RDT). Due to political and governmental limitations, the patient received only six sessions of RDT, below the standard recommended regimen. Three years post-treatment, he presented with abdominal symptoms, and imaging revealed a hepatic lesion. A liver biopsy confirmed metastatic squamous cell carcinoma. Histopathological comparison with the primary tumor supported the diagnosis of hepatic metastasis from OPSCC. This case underscores the aggressive nature of OPSCC and the critical importance of completing multimodal therapy. Interrupted adjuvant treatment may have contributed to early distant spread. While liver metastases from OPSCC are rare, they should be considered in patients presenting with compatible symptoms and a history of incomplete treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.